📰 Development Solutions News
Page 32 - Development Solutions News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Development Solutions. Real-time updates on events, politics, business and more.
August 4, 2023
IQVIA (NYSE:IQV – Get Free Report) had its price objective lifted by Stifel Nicolaus from $255.00 to $281.00 in a research report issued on Wednesday, Marketbeat reports. The firm presently has a “buy” rating on the medical research company’s stock. Stifel Nicolaus’ target price points to a potential upside of 29.53% from the stock’s current […]
August 3, 2023
IQVIA (NYSE:IQV – Get Free Report) updated its third quarter 2023 earnings guidance on Tuesday. The company provided EPS guidance of $2.39-$2.49 for the period, compared to the consensus EPS estimate of $2.60. The company issued revenue guidance of $3.76 billion-$3.81 billion, compared to the consensus revenue estimate of $3.83 billion. IQVIA also updated its […]
August 3, 2023
Bank of Marin lessened its position in shares of IQVIA Holdings Inc. (NYSE:IQV – Free Report) by 5.1% in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 3,477 shares of the medical research company’s stock after selling 185 shares during the […]
August 3, 2023
Bank of Marin cut its stake in IQVIA Holdings Inc. (NYSE:IQV – Free Report) by 5.1% in the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 3,477 shares of the medical research company’s stock after selling 185 shares during the quarter. Bank of Marin’s […]
August 2, 2023
IQVIA (NYSE:IQV – Get Free Report) issued an update on its FY23 earnings guidance on Tuesday morning. The company provided earnings per share guidance of $10.20-10.45 for the period, compared to the consensus earnings per share estimate of $10.39. The company issued revenue guidance of $15.05-15.175 billion, compared to the consensus revenue estimate of $15.26 […]
August 2, 2023
IQVIA (NYSE:IQV – Get Free Report) updated its third quarter earnings guidance on Tuesday. The company provided EPS guidance of $2.39-2.49 for the period, compared to the consensus EPS estimate of $2.60. The company issued revenue guidance of $3.76-3.81 billion, compared to the consensus revenue estimate of $3.83 billion. IQVIA also updated its FY 2023 […]
August 2, 2023
Ten Capital Wealth Advisors LLC bought a new stake in shares of IQVIA Holdings Inc. (NYSE:IQV – Free Report) in the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor bought 269 shares of the medical research company’s stock, valued at approximately $54,000. Several other hedge […]
August 2, 2023
AtonRa Partners lessened its position in shares of IQVIA Holdings Inc. (NYSE:IQV – Free Report) by 9.4% in the 1st quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 3,017 shares of the medical research company’s stock after selling 313 shares during the […]
August 2, 2023
Premier Fund Managers Ltd grew its stake in IQVIA Holdings Inc. (NYSE:IQV – Free Report) by 9.5% in the first quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 230,000 shares of the medical research company’s stock after acquiring an additional 20,000 shares during the quarter. IQVIA […]
August 2, 2023
IQVIA (NYSE:IQV – Get Free Report) had its target price hoisted by equities researchers at Morgan Stanley from $220.00 to $240.00 in a research note issued to investors on Wednesday, Benzinga reports. The brokerage currently has an “overweight” rating on the medical research company’s stock. Morgan Stanley’s price target indicates a potential upside of 9.54% […]